These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18579253)

  • 1. Estimating the budget impact of new technologies added to the National List of Health Services in Israel: stakeholders' incentives for adopting a financial risk-sharing mechanism.
    Hammerman A; Greenberg D
    Health Policy; 2009 Jan; 89(1):78-83. PubMed ID: 18579253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial risk-sharing in updating the National List of Health Services in Israel: stakeholders' perceived interests.
    Hammerman A; Feder-Bubis P; Greenberg D
    Value Health; 2012; 15(5):737-42. PubMed ID: 22867784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The process of updating the National List of Health Services in Israel: is it legitimate? Is it fair?
    Greenberg D; Siebzehner MI; Pliskin JS
    Int J Technol Assess Health Care; 2009 Jul; 25(3):255-61. PubMed ID: 19619343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Year 2006 update of the Israel National List of Health Services.
    Tamir O; Rabinovich M; Shani M
    Isr Med Assoc J; 2006 Sep; 8(9):595-600. PubMed ID: 17058406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of new medical technologies on health expenditures in Israel 2000-07.
    Rabinovich M; Wood F; Shemer J
    Int J Technol Assess Health Care; 2007; 23(4):443-8. PubMed ID: 17937832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newspaper advertising by health maintenance organizations during the reform of healthcare services in Israel.
    Reuveni H; Shvarts S; Meyer J; Elhayany A; Greenberg D
    Isr Med Assoc J; 2001 Jun; 3(6):422-6. PubMed ID: 11433635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a financial risk-sharing scheme on budget-impact estimations: a game-theoretic approach.
    Gavious A; Greenberg D; Hammerman A; Segev E
    Eur J Health Econ; 2014 Jun; 15(5):553-61. PubMed ID: 24326947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a pharmaceutical risk sharing agreement based on the purchaser's total budget.
    Zaric GS; O'brien BJ
    Health Econ; 2005 Aug; 14(8):793-803. PubMed ID: 15685669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health and budget reform as handmaidens.
    Steuerle CE; Bovbjerg RR
    Health Aff (Millwood); 2008; 27(3):633-44. PubMed ID: 18474950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk-sharing schemes: a new paradigm in adopting innovative pharmaceuticals].
    Hammerman A; Greenberg D
    Harefuah; 2012 Jun; 151(6):364-7, 376. PubMed ID: 22991869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case for user charges in public hospitals.
    Mufti MH
    Saudi Med J; 2000 Jan; 21(1):5-7. PubMed ID: 11533743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financing the package of services during the first decade of the national health insurance law in Israel: trends and issues.
    Shmueli A; Achdut L; Sabag-Endeweld M
    Health Policy; 2008 Sep; 87(3):273-84. PubMed ID: 18374446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disinvestment for re-allocation: a process to identify priorities in healthcare.
    Nuti S; Vainieri M; Bonini A
    Health Policy; 2010 May; 95(2-3):137-43. PubMed ID: 20015568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health technology assessment from a Canadian device industry perspective.
    Ferrusi IL; Ames D; Lim ME; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Updating the basket of health services].
    Israeli A; Chinitz DP
    Harefuah; 2003 Feb; 142(2):100-2, 159. PubMed ID: 12653041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding legitimacy for the role of budget impact in drug reimbursement decisions.
    Niezen MG; de Bont A; Busschbach JJ; Cohen JP; Stolk EA
    Int J Technol Assess Health Care; 2009 Jan; 25(1):49-55. PubMed ID: 19126251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meeting increased demand.
    Blair A
    Jpn Hosp; 2004 Jul; (23):19-22. PubMed ID: 19195249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early awareness and alert systems for medical technologies in Israel.
    Tal O; Hakak N
    Int J Technol Assess Health Care; 2012 Jul; 28(3):333-8. PubMed ID: 22980713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk sharing or risk shifting? On the development of patient access schemes in the process of updating the national list of health services in Israel.
    Triki N; Ash N; Porath A; Birnbaum Y; Greenberg D; Hammerman A
    Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):749-753. PubMed ID: 31825682
    [No Abstract]   [Full Text] [Related]  

  • 20. Competition and health cost containment: cautions and conjectures.
    Brown LD
    Milbank Mem Fund Q Health Soc; 1981; 59(2):145-89. PubMed ID: 6908948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.